Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
141.35
+2.34 (1.68%)
At close: Jul 2, 2025, 4:00 PM
138.80
-2.55 (-1.80%)
After-hours: Jul 2, 2025, 5:16 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Genetic Medicines
290.52M
Log In
Genetic Medicines Growth
473.02%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
290.52M
Log In
United States Growth
473.02%
Log In